WuXi Biologics
Offering End-to-End Solutions
About Us
Our Company
WuXi Vaccines, a subsidiary of WuXi Biologics, focuses on vaccine development and manufacturing. With multiple commercial vaccines manufactured at globally GMP-certified facilities, and over 38 projects in development, WuXi Vaccines brings a level of expertise, experience and state-of-the-art facilities to enable your project to be conducted right the first time. As an industry-leading CDMO, we provide world-class integrated development and manufacturing platforms to expedite your vaccine to the clinic and the market.
WuXi Vaccines views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the vaccines CDMO sector. Our facilities use next-generation biomanufacturing technologies and clean energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, enhancing our commitment to sustainability.
Regulatory Inspections Passed
Facilities Certified
Major Observation in EMA PAI
Million Doses Delivered
Countries Served in the Fight Against COVID-19
Vision
& Mission
To be an enabler for global vaccines development and manufacturing by applying the best integrated open technology platforms.
By leveraging our technical strengths, premium quality in CMC & Regulatory capabilities, technical platforms and manufacture facilities, we provide a truly end-to-end service from vaccine development to scaled-up and commercial manufacturing to any global customer.
Global Network
WuXi Vaccines leverages capabilities, capacities, and experienced staff across our global network through WuXi Biologics, to provide partners with end-to-end development and manufacturing services tailored to their innovative vaccine projects. In addition to the extensive resources available to us across China, US and Europe for clinical and commercial supply, we are establishing a global network of dedicated facilities for vaccines.
Dundalk, Ireland
WuXi Vaccines Dundalk Site is located mid-way between Dublin and Belfast, less than an hour’s drive from Ireland’s two largest cities. The site is a greenfield development of an integrated vaccine manufacturing facility to be used exclusively as part of a 20-year vaccine manufacturing contract with a global vaccine leader, valued at approximately USD $3 billion.
Dundalk site is equipped with drug substance manufacturing (DS), drug product manufacturing (DP), Manufacture Science and Technology Labs (MS&T) as well as Quality Control labs (QC).
The QC potency lab became operational in July 2020 and received the GMP certificate from Ireland Health Products Regulatory Authority (HPRA) in July 2022. Following the mechanical completion of the main manufacturing facility in October 2022, steps are underway toward commissioning, qualification and validation (CQV), tech transfer (TT), and process performance qualification (PPQ), all leading towards the launch of a great innovative vaccine.
Suzhou, China
WuXi Vaccines Suzhou Site is located in Suzhou Industrial Park with 20 minutes train journey to Shanghai. The 8,500-square-metre facility includes multiple 250L, 500L and 1000L single-use bioreactors as well as sterile drug-product manufacturing lines. The facility will be ready for GMP production in 2023. The site will become a new node within WuXi Vaccines' global network and after renovation will provide industry-leading vaccine development and GMP manufacturing services for our global partners.
Culture
Integrity, Dedication, Working Together & Sharing Success
-
Put Customers First
Exceed customers’ expectations, maximize the value for our customers, and win customers’ loyalty with a 100% customer retention rate.
-
Demonstrate Integrity
Take the initiative to promote a positive work environment where doing the right thing is the standard. Be positive and enthusiastic, approach challenges with energy and optimism.
-
Strive for Excellence
Pursue focus and expertise, and optimize processes in order to deliver excellent results. Relentlessly drive learning, accumulation, improvement and innovation.
-
Execute for Results
Drive effective execution of each project and objective, focusing on solutions and results.
-
Pursue Collaboration and Teamwork
Engage in collaboration and mutual development with an open and win-win mindset by sharing resources and leveraging the complementary advantages of each.
-
Embrace Change and Drive Innovation
Demonstrate flexibility and ability to embrace change. Adapt quickly to transformational and innovative conditions with a strong commitment to breakthroughs and development.
History & Awards
Corporate Development Footprint
Business Ethics & IP Policy
As an industry-leading CDMO for Global Vaccine Development and Manufacturing, WuXi Vaccines is committed to the highest standards of ethics and integrity. Employees, officers and directors strive to deal honestly, ethically and fairly with our suppliers, customers, competitors, employees and the communities we serve worldwide. Statements regarding the Company’s products and services must not be false, misleading, deceptive or fraudulent. WuXi Vaccines strives to conduct business with individuals and organizations who share our commitment to the highest ethical standards and who operate in a socially and environmentally responsible manner.
Intellectual Property Protection is the foundation of trust between WuXi Vaccines and our global customers. To that end, we have established the most stringent policies in China and in U.S. for the protection of intellectual property and for prosecution of IP violations.
WuXi Vaccines aligns to the rigorous and industry-leading IP protection policies of WuXi Biologics. Our purpose in business is to enable innovation for our global partners, who keep us at the top of their confidence. We guard IP protection with our founding principles of integrity, world-class security, zero-tolerance policies, and relentless pursuit of justice against any criminal act.
Environmental Social Governance (ESG)
We are dedicated to implementing sustainable and eco-friendly business practices by building a comprehensive and integrated Environmental, Health and Safety (EHS) management system, sourcing ethically, advocating reduced energy consumption, minimizing effluent, and acting responsibly to tackle climate change and reduce operational impact on the environment.
On our Diversity, Equity and Inclusion initiatives, we strive to advance a diverse workforce and create an equal and inclusive corporate culture. To this end, we recruit employees based on their professional and academic achievements regardless of religion, disability, age, race, color, sex, gender identity, sexual orientation, or marital status to provide equal employment opportunity
Along with the creation of our own compliance management system and ethical standards training programs for all employees, our “Zero tolerance” for bribery and corruption principles along with our commitment to honesty and trustworthy business conduct promote our ESG culture.
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?